Introduction
In photodynamic therapy (PDT), interaction of the excited photosensitizer with molecular oxygen results in the formation of reactive oxygen species (ROS), which can cause severe damage to the cellular constituents and are believed to be responsible for cell destruction (Henderson and Dougherty, 1992) . Two basic types of cell death, apoptosis or necrosis, can be induced by PDT. For therapy, an apoptosis which is an ordered regulated process is preferable to necrosis characterized by an uncontrolled bursting of cells followed by an inflammatory reaction (Van Cruchten and Van Den Broeck, 2002) . Many factors influence the type of cell death caused by PDT (Kessel et al., 1997; Lavie et al., 1999; Oleinick et al., 2002; Almeida et al., 2004) . For example, accumulation of a photosensitizer in mitochondria or the endoplasmic reticulum primarily results in apoptosis (Kessel, 2002) , although localization to lysosomes can also trigger the mitochondrial apoptotic pathway (Kessel et al., 1997 (Kessel et al., , 2000 Reiners et al., 2002; Ichinose et al., 2006) . Mitochondria play an important role in the early events of apoptosis (Pastorino et al., 1998) . The release of cytochrome c into the cytoplasm triggers very rapid apoptotic response with sequestered activation of cysteine proteases, caspase-9 and -3 (Liu et al., 1996) . Among caspases, an executioner caspase-3 has been implicated as a downstream effector protease that can be activated by other upstream caspases (Thornberry and Lazebnik, 1998) .
Oxidative stress activates multiple signaling pathways including mitogen-activated protein kinase (MAPK) cascades. c-Jun N-terminal kinase (JNK) and p38 MAPK were shown to be key mediators of stress signals (Hibi et al., 1993) and are often associated with apoptosis (Callsen and Brune, 1999) . The exact roles of JNK and/or p38 MAPK in PDT-induced programmed cell death remain highly ambiguous. Although activation of MAPKs was observed following photoactivation of benzoporphyrin derivative (Tao et al., 1996) , 5-aminolevulinate (Klotz et al., 1998) , hypericin (Assefa et al., 1999) , Pc4 (Xue et al., 1999) and Photofrin (Tong et al., 2002 (Tong et al., , 2003 , only in the case of Pc4 and Rose Bengal, the activation of p38 was shown to be directly connected with apoptosis (Xue et al., 1999; Zhuang et al., 2000) . In hypericin-and Photofrinmediated apoptosis, JNK and p38 MAPK are rather implicated in cellular resistance against the PDT stress (Assefa et al., 1999; Tong et al., 2002 Tong et al., , 2003 .
We have designed, prepared and tested electrondeficient polyfluorinated porphyrins (tetrakis-p-oligoethyleneglycol-tetrafluorophenyl porphyrins), where ethyleneglycol peripheral substitution enables solubility without introducing a charge. Their interaction with biological structures is governed by non-covalent hydrophobic interaction of the aromatic macrocycle with the aromatic region of biopolymers and/or selective interaction with lipophilic domains. Here, we present results of para-ethyleneglycol derivative PORF-TEG, which, although mainly localized in lysosomes, triggers apoptosis by inducing the signals that converge on mitochondria. Induction of cell death machinery by the photoactivated tetrakis-meso-(4-ethyleneglycol-2,3,5,6-tetrafluorophenyl) porphyrin (PORF-TEG) includes formation of ROS, activation of the p38 MAPK signaling pathway acting upstream of caspases, activation of proapoptotic members of the Bcl-2 family and impairment of Bcl-2 protective function. A p38 MAPK-independent mechanism is also triggered by PORF-TEG photoactivation.
Results

PORF-TEG characteristics
Preparation and elemental analysis of tetrakis-meso-(4-ethyleneglycol-2,3,5,6-tetrafluorophenyl) porphyrin derivative PORF-TEG are described in Czech patent application PV 2007-41 and are going to be published (manuscript in preparation). The structure of PORF-TEG is presented in Figure 1a and its absorption spectra in Figure 1b .
Localization of PORF-TEG to lysosomes
The intracellular localization of the novel porphyrin derivative was observed with epifluorescence and confocal microscopy. 4T1 cells exhibited punctate red fluorescence ( Figure 1c) . To identify the intracellular compartment where PORF-TEG had accumulated, co-staining with LysoTracker Green or MitoTracker Green fluorescence was performed. The merged stained images revealed that PORF-TEG colocalized to a subset of the LysoTracker-stained structures. The prevalent lysosomal localization was also observed in other cell types such as HL60, A431NS and murine embryonic fibroblasts (MEFs) (Supplementary Materials Figure 2 ). Thus, PORF-TEG is predominantly localized in lysosomes, although some cytoplasmic staining has also been observed. Photodynamic light exposure did not lead to immediate lysosomal rupture, which occurred during the advanced stages of apoptosis (Supplementary Materials Figure 3 ).
PORF-TEG-mediated PDT induces apoptosis in various tumor cell lines
To investigate the photodynamic potential of PORF-TEG, various cells were incubated with the drug and then illuminated (500-510 nm light). Generally, the type of cell death (apoptosis or necrosis) depends mostly on the photosensitizer concentration and the light dose. In the case of PORF-TEG, apoptosis was the prominent mode of cell death at 50 nM-2 mM drug concentrations and light dose of 1.7-4.0 J cm À2 . Within several hours after illumination, a large proportion of HL60-PDT-treated cells displayed nuclear fragmentation and chromatin condensation (Figures 2a and b) as well as 60-95% Annexin-positive cells (Figure 2c) . Activation of caspases was demonstrated by staining with FITC-conjugated active caspase-3 antibody (Figure 2d ), by proteolytic processing of an inactive zymogen into activated fragments and by proteolytic (c) Intracellular localization of PORF-TEG in 4T1 cells. Left panels represent confocal images of PORF-TEG; middle panels, images showing co-staining with mitochondria-or lysosomespecific probes (MitoTracker Green, LysoTracker Green); right panels, overlay images in which colocalization corresponds to orange/yellow color(s). PORF-TEG, tetrakis-meso-(4-ethyleneglycol-2,3,5,6-tetrafluorophenyl) porphyrin.
p38 MAPK activation mediates photoinduced apoptosis J Kralova et al cleavage of a substrate, poly(ADP-ribose) polymerase (PARP) (Figure 2e ). Cells subjected only to dimethylsulfoxide treatment or cells treated with PORF-TEG without light (dark control) did not show such changes (Figure 2 ). The induction of apoptosis by PORF-TEG was both lightand drug-dose dependent. As a control compound, Photofrin, photosensitizer used in clinical trials, was included ( Figure 2f ). To reach a similar level of cell death (IC 50 ), 10-to 50-fold higher concentration of Photofrin was needed compared to PORF-TEG, although the absorption spectra of both compounds are similar (Supplementary Materials Figure 1 ) and the output wavelength of the light source match the major q-band of both photosensitizers (POFR-TEG 510 nm, Photofrin 508 nm). This indicates that PORF-TEG as a pure compound has higher photodynamic potential than the complex mixture of Photofrin. To exclude cell-specific response, various cell lines (HL60, 4T1, HeLa and A431NS) were analysed and DNA laddering was found in all of them within 2-6 h post-PDT (Figure 2g ). Thus, photoactivation of the PORF-TEG derivative results in the induction of apoptosis in tumor cells of various origins.
Release of cytochrome c from mitochondria and changes in the expression of Bcl family members To determine whether mitochondria are involved in PORF-TEG-induced apoptosis, HL60 cells were fractionated into soluble (cytoplasmic) and membrane (mitochondrial) fractions after treatment. In cells (Figure 2e ). Consistent with the activation of the mitochondrial pathway, simultaneous activation of caspase-9, -8 and -3 was observed (Figure 2e ).
The onset of apoptotic events was accompanied by dramatic changes in the expression of some Bcl-2 family members, key regulators of apoptosis. The immunoblot analysis of whole-cell extracts revealed significant reduction of Bcl-2, Bak, Mcl-1 L (40 kDa), cleavage of Bad (15 kDa), activation of pro-apoptotic tBid protein (15 kDa) and the appearance of proapoptotic Mcl-1 S (30 kDa) within 30 min following PDT treatment ( Figure 3a) . The levels of Bcl-X L and Bax, however, remained unchanged.
Overexpression of Bcl-2 partially inhibits apoptosis in 4T1 cells
To demonstrate the causative importance of changes in the Bcl-2 expression in the analysed apoptotic process, the effect of overexpression of Bcl-2, an anti-apoptotic member of the Bcl family, was examined ( Figure 3b ). When 4T1 cells stably overexpressing murine Bcl-2 (4T1-Bcl-2) were exposed to PORF-TEG-mediated PDT, they were partly protected against apoptosis as shown by inhibition of caspase-3 activation and PARP cleavage ( Figure 3b ) and decrease of cell death from 79 to 40% as compared with 4T1 parental cells ( Figure 3c ). These results demonstrate that degradation of Bcl-2 plays an important role in the progression of PORF-TEG-induced apoptosis.
PORF-TEG-mediated PDT induces immediate changes in the activation of p38 and JNK1 MAPK pathways
The role of MAPK cascades as an apoptotic signaltransduction pathway has recently attracted considerable attention. The involvement of MAPK cascades in PORF-TEG photoinduced apoptosis was analysed by examining changes in the phosphorylation status of p38, JNK and extracellular signal-regulated kinase. Lysates from control and PDT-treated HL60 cells were subjected to western blot analysis using phospho-specific antibody ( Figure 4a ). In control cells (untreated-C, or treated with sensitizer without irradiation-D), the basic steady-state level of phosphorylation among MAPK kinases differed substantially. Although JNK phosphorylation was undetectable, weak or very high phosphorylation of p38 and extracellular signal-regulated kinase was found, respectively. Photostimulation resulted in a rapid induction of the p38 and JNK phosphorylation, but not extracellular signal-regulated kinase phosphorylation ( Figure 4a ). The induction of JNK reached the peak within 0.5-1 h after the treatment, whereas immediate and sustained enhancement of p38 phosphorylation was observed. MKK3/MKK6, known upstream kinases of p38, were also transiently activated by PDT (0-4 h). The rapid phosphorylation of p38 and JNK suggests that stimulation of these cascades might play a role in PORF-TEG-mediated apoptosis.
Role of MAP kinases and caspases in PORF-TEGmediated apoptosis
The induction of apoptosis in HL60 cells correlated with the activation of JNK and p38 kinases and caspases. Next, we examined whether the commitment to apoptosis is dependent on MAPK activation. For this purpose, we used p38-specific inhibitors (SB202190 or PD 169316) and JNK kinase inhibitor (SP600125). The specificity of their action is demonstrated by the reduction of phosphorylation of p38 and a downstream target of JNK, c-Jun (Figure 4b) . Pretreatment of cells with p38 inhibitors (20 mM) not only abolished p38 phosphorylation, but also attenuated PDT-induced apoptosis by 36-52%, reduced caspase activation, PARP and Mcl-1 cleavage, and Bcl-2 degradation (Figures 4c and d) . However, as expected, there was no effect on phosphorylation of MKK3/MKK6. In contrast, a generic inhibitor of JNK kinases (SP600125; 5 mM) was not able to reverse PORF-TEG-mediated apoptosis and nor was a phosphoinositide-3 kinase inhibitor (LY294002; 25 mM), suggesting that JNK1 and phosphoinositide-3 are not critical to the apoptotic action of PORF-TEG in this culture model. Pretreatment with caspase inhibitors (broad-spectrum Z-VAD-FMK or inhibitors of caspase-3 (Ac-DEVD-CHO) and (Ac-DMQD-CHO), caspase-9 (Ac-LEHD-CHO), caspase-8 (IETD-FMK)) partly protected cells against apoptosis. Importantly, the p38 inhibitor blocked the caspase activation, but the caspase inhibitors did not attenuate the phosphorylation of p38 (Figure 4c ). These results together with fast kinetics of p38 activation vs caspase activation support the idea that p38 signaling p38 MAPK activation mediates photoinduced apoptosis J Kralova et al acts upstream of the caspase pathway (Zhuang et al., 2000) . The involvement of MAP kinases in photoinduced apoptosis was further confirmed by transfection studies using dominant-negative construct of p38a (p38 DN) and JNK1 (JNK1 DN). Transiently transfected A431NS cells were incubated 24 h after transfection with PORF-TEG (200 nM) for 16 h and then irradiated (2.5 J cm À2 ). Cell death monitored the next day was decreased by 36.8% when the p38 DN construct was expressed but not in a control experiment with empty vector or JNK DN ( Figure 5 ). The expression of p38a DN was verified on immunoblot using Flag-tag and p38 specific antibodies and by partial reduction of phosphorylation of ATF2, a downstream target of p38 ( Figure 5 ). In contrast, the transfection of JNK1 DN reduced the phosphorylation of c-Jun, a JNK substrate, but did not affect PORF-TEG-induced apoptosis ( Figure 5 ). Accordingly, stable transfectants of p38 DN in HeLa and 4T1 cells, when exposed to PDT, displayed attenuated apoptosis (data not shown). Taken together, these results suggest that the activation of p38, but not JNK1, plays an important role in the cell death signaling cascades in POFR-TEG-mediated PDT.
Deletion of the p38a gene protects MEFs against apoptosis
The attenuation of PORF-TEG-mediated apoptosis by p38 pharmacological inhibitors and by p38 DN mutant suggested an important role for the p38 kinase pathway in this process. Next, we investigated whether p38 MAPK is necessary for the onset of apoptosis using MEFs with intact (wt) and inactivated p38aÀ/À (KO) gene. The loss of p38a was verified by western blot analysis. Neither p38 nor phospho-p38 expression was detected, and the phosphorylation of possible downstream targets, myc and ATF2, was lowered (Figure 6c ). It was found that although the intracellular uptake of PORF-TEG (250 nM) determined by porphyrin fluorescence was similar in both cell lines (Figure 6a ), they responded differently to irradiation (Figure 6b ). In wildtype fibroblasts (MEFs-wt), the light dose of 2.5 J cm À2 induced significant apoptosis as demonstrated by chromatin condensation (Figure 6b , left panel) and cell death (63%; Figure 6d ). MEFs-KO were remarkably resistant to PDT stress, remained mostly attached to the dish and displayed normal morphology (Figure 6b , right panel) and much lower induction of cell death (21%; Figure 6d ). These results thus clearly demonstrate that activation of the p38 MAPK pathway is important for the initiation of apoptosis. However, the presence of some dead cells indicates that p38 is not absolutely required for cell death and/or that other death pathways may be operational.
ROS scavengers attenuate p38 phosphorylation and cell death To investigate the role of ROS in the cell death process induced by PORF-TEG photosensitization, we first examined their generation using the cell-permeable dye dichlorodihydrofluorescein diacetate (DCFDA) as an indicator. Even a low light dose of 1.2 J cm À2 resulted in strong DCFDA fluorescence, in contrast to nonirradiated cells (Figure 7a) . Second, preincubation of cells with singlet oxygen ( 1 O 2 ) scavenger L-histidine and antioxidants N-acetyl cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) resulted in the inhibition of caspase-3 activation and PARP cleavage, but they were not affected by the hydroxyl radical scavenger mannitol. Importantly, phosphorylation of p38 kinase was also attenuated by L-histidine, NAC and PDTC treatment, indicating the connection between ROS formation and p38 activation (Figure 7b , Supplementary Materials Figure 5 ). The survival of cells treated with antioxidants demonstrated a reduced sensitivity to photodynamic killing by 44 to 63% (Figure 7c ). These results point out that 1 O 2 and other ROS (sensitive to NAC and PDTC but not to mannitol) are involved in the activation of the p38 pathway, which is essential for the cell death process mediated by PORF-TEG photosensitization.
Discussion
In this study, we provide evidence that PORF-TEG, a new photosensitizing compound, which is mainly localized in lysosomes, after photostimulation induces signals leading to mitochondria-driven apoptosis in various types of tumor cells. In other studies, it was suggested that an increase in the permeability of lysosomal membranes might cause release of lysosomal enzymes into the cytosol (Ollinger and Brunk, 1995) , which can directly activate pro-caspases (Hishita et al., 2001; Ishisaka et al., 2001) p38 MAPK activation mediates photoinduced apoptosis J Kralova et al tBid, a proapoptotic member of the Bcl-2 protein family Stoka et al., 2001; Reiners et al., 2002) . Subsequently, tBid translocates to mitochondria to induce the release of cytochrome c (Kim et al., 2000; Shimizu and Tsujimoto, 2000; Zhai et al., 2000) , which in turn together with Apaf-1 activates caspase-9 and then caspase-3 (Reiners et al., 2002) . The early appearance of tBid (within 30 min post-irradiation; Figure 3 ) coincides with cytochrome c release and caspase activation. We also monitored tBid translocation to mitochondria following PDT in cells expressing Bid as a d4EGFP fusion protein ( Supplementary  Materials Figure 4 ). In death receptor-mediated apoptosis, the activation of caspase-8 occurs upstream of Bid prior to cytochrome c release from mitochondria (Ahmad et al., 2000) . However, almost simultaneous kinetic change of tBid, cytochrome c and caspase activation following PORF-TEG photostimulation makes it difficult to dissect the sequence of these events. In experiments using caspase inhibitors, pretreatment of cells with broad-spectrum inhibitor z-VAD-fmk and caspase-3 and -9 inhibitors attenuated Bid processing more efficiently than caspase-8-specific inhibitor IETDfmk (Figure 4) . This observation suggests together with the results of others (Granville et al., 1998; Oh and Lee, 2004 ) that caspase-8 activation might act downstream of caspase-3 and -9 as an amplification loop. Presumably, in our system, Bid cleavage is primarily mediated by some other protease, which is partly sensitive to caspase inhibitors. Since PORF-TEG is mainly localized in lysosomes, one would envision that the main candidates would be lysosomal cathepsins. However, so far we were not able to prove their potential involvement in PORF-TEG-induced apoptosis, leaving the identity of Bid cleaving protease(s) still unknown.
PORF-TEG-induced activation of p38 MAPK is fundamental in inducing apoptotic cell death as demonstrated by pharmacological inhibitors and by overexpression of p38a DN mutant. The conclusive evidence came from experiments using cells with the inactivated p38a gene (MEFs-KO), which were not prone to PDT stress signal. Although the major role of the p38a isoform was shown, a possible role for other p38 isoforms (b, g, and d) in PORF-TEG-mediated oxidative stress cannot be excluded, and further studies are needed to delineate their expression and involvement.
Another question to be answered is at which level p38 stress kinase is coupled to the caspase pathway. Because p38 MAPK activation mediates photoinduced apoptosis J Kralova et al the inhibition of caspase activation was achieved by p38 inhibitors but inactivation of caspase-3, -8, and -9 did not inhibit p38 phosphorylation in HL60 cells, these caspases likely act downstream of p38. p38 MAPK may act to alter mitochondrial function via a direct pathway, since p38a causes apoptosis in a lymphoblastoid B-cell line by translocating directly to the mitochondria (Rosini et al., 2000) . In our model, the detection of ROS formation coincides with p38 activation. Moreover, the p38 activation can be attenuated by 1 O 2 scavenger Lhistidine and other antioxidants NAC or PDTC, thus indicating involvement of singlet oxygen as well as other reactive oxygen species. Since diffusion of 1 O 2 , a shortlived excited state of oxygen, is rather limited, it is likely that sites of PORF-TEG localization, lysosomes and cytoplasm, would also be sites of its production, while other ROS (superoxide anion, hydrogen peroxide, etc.) might be released from mitochondria as second messengers during apoptosis (Matroule et al., 2001) . Our data support the model where photostimulation leads to the formation of singlet oxygen activating p38 MAPK, which in turn induces the mitochondrial pathway. This conclusion is in agreement with the report of Zhuang demonstrating the role of p38 in singlet oxygen apoptosis (Zhuang et al., 2000) . Another signal (p38-independent) might be produced by released lysosomal proteases that in turn activate caspases, Bid processing and thus lead to the amplification of the apoptotic process. This conclusion seems to be also supported by incomplete inhibitory effect of p38 inhibitors on caspase activation and PARP cleavage.
In addition, alterations in the level of expression of several Bcl-2 family members contribute significantly to the propagation of PORF-TEG-mediated apoptosis. Cells exposed to photodynamic treatment exhibit significant degradation of anti-apoptotic Bcl-2 resulting in the loss of its protective function (Usuda et al., 2003) . In contrast, overexpression of Bcl-2 partially protects cells against caspase activation, PARP cleavage and PDT-induced cell death. Similar results were obtained in the CHO cell line using Pc4 sensitizer (He et al., 1996) , or benzoporphyrin derivative in HL60 cells (Granville et al., 1999) . Moreover, pharmacological inhibition of p38 in 4T1-Bcl-2 cells resulted in an additional anti-apoptotic effect (data not shown). Recently, it has been reported that the antiapoptotic effect of Bcl-2 can be regulated under conditions of cellular stress by p38 MAPK-mediated phosphorylation. The phosphorylation of Bcl-2 Ser 87 and Thr 56 residues is associated with a decrease in the antiapoptotic potential of Bcl-2 protein (De Chiara et al., 2006) . Indeed, a slight increase of Bcl-2 phosphorylation correlating with a decline of Bcl-2 protein level in our experiments might indicate such mechanism (data not shown). Importantly, both cytochrome c release and caspase activation triggered by p38 MAPK activation and Bcl-2 phosphorylation are absent in p38a MEFs- KO (De Chiara et al., 2006) . In addition, proapoptotic members of the Bcl-2 family, cleaved Bad and Mcl-1S, might further contribute to (b) ROS scavengers attenuate p38 phosphorylation, caspase activation and PARP cleavage. PORF-TEG-loaded cells were preincubated with ROS scavengers L-histidine (line 4), NAC (line 5), PDTC (line 6) and mannitol (line 7) for 1 h. Two hours after irradiation, cell lysates were analysed on western blot. As controls, we used cells treated without irradiation (line 1), irradiated cells (line 2) and cells pre-treated with p38 inhibitor PD 169316 (line 3). (c) ROS scavengers reduce sensitivity to photodynamic killing. Cell viability was evaluated 24 h post-PDT. Results represent the mean of three independent experiments. DCFDA, dichlorodihydrofluorescein diacetate; NAC, N-acetyl cysteine; PARP, poly(ADP-ribose) polymerase; PDT, photodynamic therapy; PORF-TEG, tetrakismeso-(4-ethyleneglycol-2,3,5,6-tetrafluorophenyl) porphyrin; ROS, reactive oxygen species.
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Although SAPK/JNK and p38 pathways are stimulated by oxidative stress mediated by both Photofrin and PORF-TEG, only in PORF-TEG-induced apoptosis, the p38/caspase activation was found to be essential. The reasons for such striking difference likely reside in the molecular structure of photosensitizers and resultant biolocalization and/or binding to molecular targets. Photofrin represents a mixture of different porphyrins, localizing in the plasma membrane and the Golgi complex (Hsieh et al., 2003) or in mitochondria (Saczko et al., 2007) . In contrast, PORF-TEG is a designed molecule with preferential hydrophobic interaction with lipophilic domains and with main localization in the lysosomes and cytoplasm. The identification of PORF-TEG molecular targets will be of great importance in the definition of the triggering apoptotic signal. Experiments in such a direction are in progress. In addition, it is still unclear what upstream MAPK kinases act as mediators of apoptosis induced by PORF-TEG PDT. Immediate transient activation of MKK3/MKK6 indicates involvement of these kinases in the p38 pathway, but the identity of further upstream MAPK kinase kinases remains to be elucidated.
In summary, PORF-TEG represents a novel non-mitochondrially localized compound with profound ability to induce apoptosis in various tumor cell lines. It functions mainly via activation of the p38 signaling cascade, leading to mitochondrially driven apoptosis.
Materials and methods
Chemicals and antibodies
Synthesis and elemental analysis of PORF-TEG used in this study are described in Czech patent application PV 2007-41 and are going to be published (manuscript in preparation). The stock solution (1 mM) was made in dimethylsulfoxide. Photofrin (Axcan Pharma International, Sittard, The Netherlands) was dissolved in 5% dextrose in water. The media and supplements were from Sigma (St Louis, MO, USA), fetal calf serum from PAA Laboratories GmbH (Pasching, Germany).
Antibodies recognizing phospho-c-Jun (Ser73), phospho-p44/42 MAP kinase (Thr202/Tyr204), phospho-ATF-2 (Thr71), phospho-c-Myc (Thr58/Ser62), phospho-MKK3/ MKK6 (Ser189/207), phospho-p38 MAPK (Thr180/Tyr182), phospho-SAPK/JNK (Thr183/Tyr185), caspase-3, -8, and -9, SAPK/JNK, p38 MAP kinase, MKK3 kinase, Bcl-X L and Bcl-2 were from Cell Signaling Technology Inc. (Beverly, MA, USA); Bcl-2 (DC 21), , Bad (C-7), Bid , caspase-8 p20 and c-Jun were from Santa Cruz Biotechnology (Santa Cruz, CA, USA); Bcl-2, BAK, cytochrome c and PARP were purchased from BD Biosciences Pharmingen (San Diego, CA, USA); actin from Sigma.
Kinase inhibitors PD 169316, SB202190, SP600125 and negative controls were from Calbiochem (San Diego, CA, USA), LY294002 from Cell Signaling Technology Inc., caspase inhibitors Z-VAD-FMK, Ac-DMQD-CHO, Ac-DEVD-CHO, Ac-IETD-CHO and Ac-LEHD-CHO were from Alexis (Lausen, Switzerland) and inhibitor IETD-FMK was from BD Biosciences (Palo Alto, CA, USA).
ROS quenchers D-mannitol, L-histidine, NAC and PDTC were purchased from Sigma.
For cell staining, Hoechst 33342 and propidium iodide were from Sigma, Annexin-V-Fluos from Roche (Mannheim, Germany) and FITC-conjugated monoclonal active caspase-3 antibody kit was from BD Biosciences Pharmingen. All other chemicals used in this study were purchased from Sigma.
Cell cultures
All cell lines were purchased from American Type Culture Collection (Manassas, VA, USA). Cell lines HL60 (human promyelotic leukemia), 4T1 (mouse mammary carcinoma) were kept at exponential growth in RPMI 1640 medium with 10% fetal calf serum (Kralova et al., 2006) . A431NS (human epidermoid carcinoma), HeLa (human cervical carcinoma), MEFs-wild-type (wt) and p38aÀ/À (KO) a kind gift of EMBL researcher Dr AR Nebreda) were grown in Dulbecco's modified Eagle's medium with antibiotics and 10% fetal calf serum.
Photosensitization and cell death determination Cells (7 Â 10 5 HL60 or 2-3 Â 10 5 4T1, HeLa and A431NS) seeded in 35 mm dishes were grown overnight at 37 1C, 5% CO 2 . PORF-TEG at a final concentration of 50-500 nM was added for 16 h before irradiation. Cells were rinsed with PBS, refed with fresh medium without phenol red for 1 h and then illuminated by a 75 W halogen lamp with a band pass filter (Andover, Salem, NH, USA) with resulting wavelength 500-510 nm. The fluence rate at the level of cell monolayer was 0.7 mW cm À2 and total light dose ranged from 1.2 to 4.2 J cm À2 . Following irradiation, the viability of post-PDT cultures was determined next day by the Trypan blue exclusion method. Control 'dark' experiments (without illumination) were performed in parallel.
Microscopic studies
Cells grown on coverslips in 35-mm Petri dishes were incubated with 0.5 mM PORF-TEG in the complete medium for 16 h. After washing, PORF-TEG fluorescence was observed with the DM IRB, Leica microscope equipped with the DFC 480 camera using a Â 100 oil immersion objective and Leica filter cube N2.1 (excitation filter BP 515-560 nm and long pass filter LP 590 nm for emission).
Annexin-V-Fluos staining of PDT-treated cells was performed in working solution supplemented with propidium iodide as suggested by the manufacturer for 15 min and then analysed by fluorescence microscopy using Leica filter cubes I3 (excitation filter BP 450-490 nm and long pass filter LP 515 nm for emission) for FITC and N2.1 for propidium iodide (PI) fluorescence.
For detection of ROS, 4T1 cells were sequentially loaded with 350 nM PORF-TEG and 10 mM dichlorodihydrofluorescein diacetate (Molecular Probes, Eugene, OR, USA) in PBS for 30-45 min at 37 1C. After washing and adding growth media, cells were exposed to a light dose of 1.2 J cm À2 and immediately analysed under a fluorescence microscope using FITC filter.
Nuclei in PDT-treated cells were stained with Hoechst 33342 (5 mM final concentration) for 30 min at 37 1C and visualized using Leica filter cube A (excitation filter BP 340-380 nm and long pass filter LP 425 nm for emission). PI staining (50 mg ml
À1
for 1 h at 4 1C) was performed on cells fixed with cold 70% ethanol, permeabilized with Triton X-100 and RNase treated (100 U ml À1 ) at room temperature for 10 min. The subcellular localization of PORF-TEG in 4T1 tumor cells was studied using confocal laser scanning microscopy. Cells after PORF-TEG incubation were loaded with 75 nM p38 MAPK activation mediates photoinduced apoptosis J Kralova et al
MitoTracker Green (Molecular Probes) for 15 min or with 500 nM LysoTracker Green (Molecular Probes) for 1 h at 37 1C in the complete medium. Cells were washed with PBS three times, overlaid with colorless media and examined under a Leica TCS SP confocal microscope with Ar (488 nm) laser using a Â 100 oil immersion objective. The emission spectrum of PORF-TEG was detected between 640 and 700 nm. In the same cells, the emission spectra of green MitoTracker or LysoTracker were detected between 500 and 550 nm. Experiments were repeated three times in a minimal ambient light.
DNA analysis
DNA isolation and analysis from PDT-treated cells were performed as described before (Kralova et al., 2006) . After staining with ethidium bromide, DNA was visualized under electronic dual wave ultraviolet transilluminator (Ultra Lum Inc., Claremont, CA, USA) 365/254 nm.
Transfections of DN mutants and Bcl-2 JNK1 DN in pcDNA3 vector and p38a DN (pCMV5-Flagp38) were kindly donated by Dr Roger Davis (Howard Hughes Medical Institute, MA, USA). The p38a gene was subcloned into BamHI and XbaI sites of pcDNA3.1 vector as BglII-XbaI fragment. A431NS cells (7 Â 10 5 per 35 mm dish) were transfected with 4 mg of DNA using Lipofectamine 2000 (Invitrogen, Paisley, UK) in culture medium without antibiotics in the presence of 3% fetal calf serum. After 4 h, serum was increased to 10%. Next day the medium was replaced, cells were incubated overnight in the presence of 250 nM PORF-TEG and after washing subjected to PDT (2.5 J cm À2 ). Cells were harvested 4-6 h later for protein analysis or assayed next day for cell death.
4T1 cells were transfected with murine Bcl-2 in pSFFV-Neo expression vector using the calcium phosphate method and stable transfectants selected by G418.
Western immunoblot analysis
Cellular extracts were prepared at various intervals after PORF-TEG-mediated PDT, separated on 10-15% sodium dodecyl sulfate-PAGE and processed for western blot analysis as described (Kralova et al., 2003) To determinate the MAPK activity, phospho-specific antibodies were used at first and then the membranes were stripped and reprobed with antibodies to total MAPK. Equal protein loading was verified by Ponceau S staining and actin reprobing. The procedure described by Reiners et al. (2002) was used to detect the release of cytochrome c from mitochondria. The cytosolic preparations were analysed on 15% gels, and the presence of cytochrome c was determined by the specific antibody.
Inhibitor and scavenger experiments
Cell preincubated with PORF-TEG were treated with kinase and caspase inhibitors for 1 and 2 h, respectively, prior to and for the duration of irradiation. Two hours post-PDT cells were either harvested for protein analysis or further incubated at 37 1C up to next day for viability determination.
Kinase and caspase inhibitors were applied as follows: p38 MAP kinase inhibitors (PD169316, SB202190) and its negative control (SB202474) were applied at 20 mM final concentration; 5 mM JNK inhibitor II (SP600125) and its negative control; 10 mM phosphoinositide-3 kinase inhibitor (LY294002); 100 mM caspase family inhibitor (Z-VAD-FMK); and caspase-3 inhibitors (Ac-DMQD-CHO and Ac-DEVD-CHO); 20 mM caspase-8 inhibitor (Ac-IETD-CHO), caspase-9 inhibitor (Ac-LEHD-CHO) and 10 mM caspase-8 inhibitor IETD-FMK.
Scavengers L-histidine (20 mM), D-mannitol, (100 mM), NAC (25 mM) and PDTC (300 mM) were incubated with cells at 37 1C for 1 h and then cells were subjected to 2.5 J cm À2 irradiation followed by incubation in the dark for another 2 h for cell lysate preparation or 24 h for viability determination.
